Search
Now showing items 1-1 of 1
Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
(TURKISH NEUROLOGICAL SOC, 2017)
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system and is characterized by inflammation, demyelination, and axonal loss. Fingolimod is the first oral drug for the treatment of MS approved ...